A new antibody has been developed to block immune suppression in aggressive breast cancer, offering a promising treatment.
NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback